Clincosm LogoSign in Get a demo

recurrent or metastatic npc

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

Recurrent or Metastatic NPC Trial in China, Singapore, Taiwan (TORIPALIMAB INJECTION(JS001 ) combine with chemo, Placebos)

Active, not recruiting
Has Results
  • Recurrent or Metastatic NPC
  • TORIPALIMAB INJECTION(JS001 ) combine with chemotherapy
  • Placebos
  • Beijing, Beijing, China
  • +31 more
Apr 15, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (axitinib)

Completed
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Apr 24, 2017